Drugs & OTC

BTC Health Limited (ASX:BTC) Shareholder Update - September 2021

🕔9/3/2021 9:23:17 AM

I am pleased to provide you with a detailed update on BTC Health Limited's (ASX:BTC) investments, along with an operational update of BTC's wholly owned investee companies.

Read Full Article

Anatara Lifesciences Limited (ASX:ANR) Launches IBS-D Clinical Trial Recruitment Website

🕔8/20/2021 8:13:43 AM

Anatara Lifesciences Limited (ASX:ANR), a developer of evidence based solutions for gastrointestinal diseases in animals and humans, is pleased to announce the launch of its IBS-D Clinical Trial recruitment website.

Read Full Article

BTC Health Limited (ASX:BTC) Annual Report - 30 June 2021

🕔8/17/2021 5:24:28 PM

The primary objective for BTC Speciality Health is to increase market share through organic growth. New products will continue to be sourced by BioImpact and will enable BTC Speciality Health to expand its product range within pain management and critical care.

Read Full Article

VGI Health Technology Limited (NSX:VTL) Certification of NE1-Elite(R)

🕔8/12/2021 9:30:00 AM

Invictus Nutraceuticals, Inc. (Florida, USA), a wholly owned subsidiary of VGI Health Technology Limited (NSX:VTL), is pleased to announce that it has partnered with Informed Sport to certify its NE1-Elite(R) product.

Read Full Article

Anatara Lifesciences Limited (ASX:ANR) Successful Piglet Study

🕔8/6/2021 9:02:29 AM

Anatara Lifesciences (ASX:ANR), a developer of evidence based solutions for gastrointestinal diseases in animals and humans, is pleased to announce the successful completion of a challenge study in weaner piglets with its recently developed bromelain-based formulation (BONIFF).

Read Full Article

Anatara Lifesciences Limited (ASX:ANR) Monthly Activities Report

🕔7/28/2021 10:29:48 AM

Anatara Lifesciences Limited (ASX:ANR), a developer of evidence based solutions for gastrointestinal diseases in animals and humans, is pleased to provide this activities report for the quarter ending 30 June 2021 (Q4 FY21), along with the Company's Appendix 4C cash flow report.

Read Full Article

Anatara Lifesciences Limited (ASX:ANR) Chair Transition

🕔7/26/2021 10:14:43 AM

Anatara Lifesciences (ASX:ANR), a developer of evidence-based solutions for gastrointestinal diseases in humans and animals, is pleased to announce the transition of Dr David Brookes from Non-Executive Director to Chairman.

Read Full Article